iSpecimen
ISPC
5 hedge funds and large institutions have $63.7K invested in iSpecimen in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
0.06% more ownership
Funds ownership: 0.09% → 0.16% (+0.06%)
33% less capital invested
Capital invested by funds: $94.9K → $63.7K (-$31.2K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$20.4K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.47K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
Bridgeway Capital Management
Houston,
Texas
| $23.1K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $23K | +$20.4K | +269 | +98% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $11.4K | +$20.4K | +268 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $3.16K | +$5.47K | +72 | +2,400% |
|
5
BlackRock
New York
| $3K | – | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $7 | – | – | – |
|
|
S
7
Sachetta
Lynnfield,
Massachusetts
| $3 | – | – | – |
|
|
SS
8
SBI Securities
Tokyo,
Japan
| $2 | – | – | – |
|
ISPC Hedge Fund Activity: Q1 2025 in Review
5 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q1 2025, worth a combined $63.7K — down 33% from $94.9K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ISPC positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $20.4K.
- 5 institutional investors held iSpecimen (ISPC) as of Q1 2025, up from 4 in Q4 2024.
- Funds reported $63.7K of iSpecimen stock for Q1 2025, down 33% quarter-over-quarter.
- 1 fund opened new iSpecimen positions in Q1 2025 and 0 closed out, a net change of +1 holder.
- The largest iSpecimen buyer in Q1 2025 was UBS Group, an estimated $20.4K added.
Based on aggregated 13F filings for Q1 2025.